15 Aug 2007
Research Triangle Park, North Carolina - Pharmaceutical manufacturer, Talecris Biotherapeutics, Inc., has said that future products in its Gamunex range will be latex-free. In a release, the comapny said, "elimination of latex from the rubber stoppers used in the product packaging, [means] physicians can confidently use Gamunex in their patients with latex allergy."
Gamunex is the preferred liquid immune globulin intravenous among allergists/immunologists surveyed, according to Harris Interactive. The new latex-free vials are currently being shipped and are becoming available to US healthcare practitioners and patients.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Gamunex
Subscribe for unlimited access. A subscription to European Rubber Journal includes:
Already a subscriber? Log in here
